No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:24110800-24113400 |
Enhancers |
Fetal Kidney |
kidney
|
2 |
chr20:24111000-24117200 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
3 |
chr20:24111400-24117200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
4 |
chr20:24111400-24120400 |
Enhancers |
Placenta |
Placenta
|
5 |
chr20:24111600-24115800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr20:24111600-24119600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
7 |
chr20:24111800-24113000 |
Enhancers |
HUVEC |
blood vessel
|
8 |
chr20:24111800-24115600 |
Enhancers |
HMEC |
breast
|
9 |
chr20:24111800-24116400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
10 |
chr20:24112000-24113000 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
11 |
chr20:24112000-24113000 |
Enhancers |
Esophagus |
oesophagus
|
12 |
chr20:24112000-24115000 |
Weak transcription |
HUES48 Cell Line |
embryonic stem cell
|
13 |
chr20:24112200-24113600 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
14 |
chr20:24112200-24114800 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
15 |
chr20:24112400-24113000 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
16 |
chr20:24112600-24112800 |
Flanking Active TSS |
NHEK |
skin
|
17 |
chr20:24112600-24113000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
18 |
chr20:24112600-24113000 |
Enhancers |
Pancreas |
Pancrea
|
19 |
chr20:24112600-24113200 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
20 |
chr20:24112600-24113400 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
21 |
chr20:24112600-24113400 |
Enhancers |
Fetal Heart |
heart
|